Curing cancer and cleaning our oceans? Here’s why I’m betting on biotech Opinion Something that can cure cancer and clean our oceans? Biotech sounds too good to be true, but some things really are just like magic, writes Andrew Craig.
Bivictrix quits London’s AIM to chase private funding as market ‘undervalues’ firm Markets Biotech firm Bivictrix Therapeutics is the latest company to exit the London Stock Exchange’s AIM market, citing difficulties in raising funds compared to its privately-owned competitors. The company, which is headquartered in Macclesfield, said it would not be able to raise enough capital to advance its medication to a clinical trial via London’s junior market [...]
Destiny Pharma is latest to leave London in pursuit of private funding TECH Biotech business Destiny Pharma has become the latest firm to de-list from the London Stock Exchange after it said it would have access to a "larger pool of capital" as a private company.